Zimmer Announces FDA Clearance Of The Stand-alone Optio-C Anterior Cervical System For Use With Structural Allograft/Autograft

By: via Benzinga
Zimmer Spine, a division of Zimmer Holdings, Inc., (NYSE: ZMH and SIX: ZMH), today announced the recent FDA 510(k) clearance of the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.